by FBorchert | May 16, 2024 | News
We are proud to announce that the dosimetry software QDOSE® designed by us and our development partner Quantinm AB will now become part of a commercial partnership with Telix. Telix intends to integrate the platform into its therapeutic radiopharmaceutical programmes...
by FBorchert | May 10, 2024 | News
Summer 2024 is coming up and as every year we are returning to the SNMMI 2024 in Toronto, Canada on June 8-11. Our two General Managers, Dr. Andreas Kluge and Andreas Fintelmann, and the CEO of ABX-CRO INC, Moritz Kallerhoff, will be there again accompanied by our...
by FBorchert | Apr 15, 2024 | Jobs
Sie sind auf der Suche nach einer neuen Herausforderung? Sie wollen mit Ihrer Arbeit einen sinnvollen Beitrag zur Gesellschaft leisten? Dann kommen Sie zu uns als Systemadministrator (m/w/d) in Festanstellung am Standort Dresden Um unser Experten-Team...
by FBorchert | Feb 26, 2024 | News
This year we will start our conference activities in Santiago, Chile for the 7th Theranostics World Congress. From March 22 to 24 you can find us at booth #A06 and talk with Dr. Andreas Kluge and Andreas Fintelmann, our General Managers, about how ABX-CRO can help you...
by FBorchert | Dec 18, 2023 | News
Prostate cancer awareness month may already be over, but men’s health remains an important topic. We are therefore most pleased to announce that ABX-CRO was chosen to collaborate with Curasight in a phase 2 study to improve the diagnosis of prostate cancer. The...
